Stocktoria

UNITED THERAPEUTICS Corp UTHR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1999-06-17 · LEI

UNITED THERAPEUTICS Corp statistics & valuation

Market cap$23.3B
P / E17.4×
P / S7.3×
P / B3.3×
P / FCF22.4×
Net margin41.9%
Return on equity18.8%
FCF margin32.7%
Return on capital20.4%
Graham number -40.4%$304.74

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($304.74); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
28.20% 37.60% 42.30% 41.50% 41.90% 2016201720182019202020212022202320242025
Gross margin (%)
91.90% 92.70% 92.70% 92.20% 88.90% 89.20% 87.90% 2016201720182019202020212022202320242025
Operating margin (%)
66.40% 47.20% 49.50% -12.90% 40.00% 33.00% 50.60% 50.90% 47.90% 46.90% 2016201720182019202020212022202320242025
Return on equity (%)
12.00% 15.20% 16.50% 18.50% 18.80% 2016201720182019202020212022202320242025
Shares outstanding
46.8M 44.9M 44.0M 43.9M 44.6M 47.3M 48.5M 49.7M 48.5M 47.9M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
9.20% 12.00% 13.70% 16.20% 16.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
37.90% 22.50% 36.50% -20.00% 46.90% 28.30% 34.30% 32.10% 37.60% 32.70% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$15.25 $9.31 $13.39 -$2.39 $11.54 $10.06 $15.00 $19.81 $24.64 $27.86 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

UNITED THERAPEUTICS Corp trades at about 18.4× earnings — above its 10-year norm (10-year range 8.6×–20.1×, median 14.2×).

8.6× 20.1×

Shaded band = 10-year range (8.6×–20.1×); dot = today's 18.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin87.9%89.2%88.9%92.2%92.7%92.7%91.9%———
Operating margin46.9%47.9%50.9%50.6%33.0%40.0%-12.9%49.5%47.2%66.4%
Net margin41.9%41.5%42.3%37.6%28.2%—————
FCF margin32.7%37.6%32.1%34.3%28.3%46.9%-20.0%36.5%22.5%37.9%
Return on assets16.9%16.2%13.7%12.0%9.2%—————
Return on equity18.8%18.5%16.5%15.2%12.0%—————
Current ratio6.605.254.419.857.616.704.036.393.264.29

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.